Severe 5-Fluorouracil Toxicity in a Patient with Decreased Dihydropyrimidine Dehydrogenase Activity
Alan P. Lyss, Rogério Lilenbaum, Barry Harris et al. · Cancer Investigation · 1993
(1993). Severe 5-Fluorouracil Toxicity in a Patient with Decreased Dihydropyrimidine Dehydrogenase Activity. Cancer Investigation: Vol. 11, No. 2, pp. 239-240.
Cited by 66 works. doi:10.3109/07357909309024846 Open-access PDF
Authors
References
- Clinical Pharmacology of 5-Fluorouracil
- Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity.
- Familial Pyrimidinemia and Pyrimidinuria Associated with Severe Fluorouracil Toxicity
- Degradation of pyrimidines and pyrimidine analogs—Pathways and mutual influences
- Metabolism of pyrimidine analogues and their nucleosides
- Systemic Therapy in Resectable Breast Cancer